PT Kimia Farma Tbk (ISX:KAEF) Accounts Payable: Rp1,850,646 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:KAEF PT Kimia Farma Tbk ISX:KAEF
54 GF Score
Price Rp456.00
GF Value Rp581.23
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Kimia Farma Tbk Accounts Payable?

PT Kimia Farma Tbk ISX:KAEF -0.87% 54 Accounts Payable is Rp1,850,646 Mil as of Mar. 2026. GuruFocus rates ISX:KAEF with a GF Score™ of 54/100 and a GF Value™ of Rp581.23 (Modestly Undervalued). The stock has 4 warning signs investors should review.

PT Kimia Farma Tbk's Accounts Payable for the quarter that ended in Mar. 2026 was Rp1,850,646 Mil.

PT Kimia Farma Tbk's quarterly Accounts Payable declined from Sep. 2025 (Rp1,773,439 Mil) to Dec. 2025 (Rp1,589,623 Mil) but then increased from Dec. 2025 (Rp1,589,623 Mil) to Mar. 2026 (Rp1,850,646 Mil).

PT Kimia Farma Tbk's annual Accounts Payable declined from Dec. 2023 (Rp1,967,139 Mil) to Dec. 2024 (Rp1,738,783 Mil) and declined from Dec. 2024 (Rp1,738,783 Mil) to Dec. 2025 (Rp1,589,623 Mil).

PT Kimia Farma Tbk Accounts Payable Related Terms

PT Kimia Farma Tbk Accounts Payable Historical Data

* Premium members only.

The historical data trend for PT Kimia Farma Tbk's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Kimia Farma Tbk Accounts Payable Chart

PT Kimia Farma Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,266,434.36 1,468,465.66 1,967,139.38 1,738,783.00 1,589,622.63

PT Kimia Farma Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,748,964.91 1,896,351.45 1,773,438.91 1,589,622.63 1,850,646.49
ISX:KAEF
54GF Score
PT Kimia Farma Tbk ISX:KAEF
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Kimia Farma Tbk Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of Rp1,850,646 Mil mean?
PT Kimia Farma Tbk (ISX:KAEF) has a Accounts Payable of Rp1,850,646 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on PT Kimia Farma Tbk and its competitors.
Is PT Kimia Farma Tbk's Accounts Payable too high?
PT Kimia Farma Tbk's current Accounts Payable is Rp1,850,646 Mil. Overall, PT Kimia Farma Tbk has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kimia Farma Tbk's Accounts Payable compare to MCK and CAH?
PT Kimia Farma Tbk's Accounts Payable of Rp1,850,646 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Distribution company?
A good Accounts Payable depends on the Medical Distribution industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on PT Kimia Farma Tbk and its competitors. PT Kimia Farma Tbk's current Accounts Payable is Rp1,850,646 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kimia Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kimia Farma Tbk (ISX:KAEF) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp581.23, compared to a current price of Rp456.00 — trading 21.5% below its estimated fair value. The current Accounts Payable is Rp1,850,646 Mil. PT Kimia Farma Tbk's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For PT Kimia Farma Tbk (ISX:KAEF), the current Accounts Payable is Rp1,850,646 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Kimia Farma Tbk (ISX:KAEF) Overvalued in 2026?

Based on GuruFocus' analysis, PT Kimia Farma Tbk stock appears to be undervalued. The current stock price of Rp456.00 is trading 21.5% below its estimated GF Value™ of Rp581.23. GuruFocus considers PT Kimia Farma Tbk to be Modestly Undervalued.

Key valuation signals for ISX:KAEF:

  • Accounts Payable: Rp1,850,646 Mil
  • GF Value™: Rp581.23 vs. price of Rp456.00 (21.5% below fair value)
  • GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Kimia Farma Tbk Business Description

Address Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
54GF Score

Get the complete analysis for ISX:KAEF

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp456.00
Price
Rp581.23
GF Value